ISRCTN12131979已完成未知
Prospective, epidemiological, clinical and laboratory programme to plan and evaluate strategies to control enteric fever in different settings in Africa and Asia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 423,618
研究概览
简要总结
2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28674145 protocol 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34798028/ (added 03/02/2022)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Census study, WASH and HUS survey:
- •Census participants will be the population (n =100,000, all ages) residing in a demarcated geographic area that is a known catchment population for each of the 3 typhoid surveillance sites. Participants will be recruited and consented as households.
- •1. Head of household / key informant is willing and competent to give informed consent for participation of the household in the study
- •2. Head of household / key informant is Male or Female, aged 18 years or above
- •3. Household is within the census area
- •Passive surveillance:
- •This component will include all patients presenting at any of the clinical surveillance sites in each country with a history of subjective fever >72 hours with or without objective fever on presentation.
- •1. Individual willing and competent to give informed consent if =18 years or the parent/legal guardian if participant <18 years;
- •2. Able to comply with study requirements
- •3. In addition those considered index cases (for the household contact component) must be resident in a household enrolled in the census survey
- •Household contacts (index cases):
- •From each site at least 73 households with index cases identified by the hospital surveillance component will be visited and all individual members of the household enrolled for the household contact study.
- •(Resident in same household as index case (identified from passive surveillance study) in whom enteric fever has been confirmed by a positive blood culture for S. Typhi or S. Paratyphi;
- •1. Individual willing and competent to give informed consent if =18 years or the parent/legal guardian if participant <18 years
- •2. Able to comply with study requirements
- •Serosurveillance:
- •Individual, age stratified participants (0-4 years, 5-9 years, 10-14 years >14 years) will be randomly selected from the census population.
- •1. Individual willing and competent to give informed consent if =18 years or the parent/legal guardian if participant <18 years
- •2. Male or female
- •3. Able to comply with study requirements
- •4. Resident in census area
- •Household contacts (of suspected chronic carriers identified in serosurvey):
- •Individuals resident in 50 households of suspected chronic carriers will be approached to request blood and stool samples in order to assess risk of infection in this group.
- •1. Resident in the same household as suspected chronic carrier identified in the serosurvey;
- •2. Individual willing and competent to give informed consent if =18 years or the parent/legal guardian if participant <18 years;
- •3. Able to comply with study requirements.
排除标准
- •Census study, WASH and HUS survey:
- •1. Head of household/key informant not willing for household to participate
- •2. Unable to identify Head of household/key informant
- •Passive surveillance:
- •1. Previous enrolment into this component (e.g. from previous attendance at healthcare facility with persistent fever)
- •2. Other underlying disease which can be rapidly diagnosed such as Malaria in children (Blantyre)
- •Household contacts (index cases):
- •1. Not a resident of household of index case at time of his/her primary illness
- •2. Fever at presentation in index case confirmed not due to S. Typhi or Paratyphi fever
- •3. Deemed clinically unsuitable by the survey team (e.g. terminally ill)
- •Serosurveillance:
- •1. Not resident in the census area
- •2. Deemed clinically unsuitable by the survey team (e.g. terminally ill)
- •Household contacts (of suspected chronic carriers identified in serosurvey):
- •1. Not a resident of household of suspected chronic carrier at time of the visit
- •2. Deemed clinically unsuitable by the survey team (e.g. terminally ill)
研究者
相似试验
已完成
不适用
VASO - Vitamin D and arthroplasty surgery outcomesSpecialty: Musculoskeletal disorders, Primary sub-specialty: OtherUKCRC code/ Disease: Musculoskeletal/ Other osteopathiesMusculoskeletal DiseasesOsteoarthritisISRCTN14533082orthumbria Healthcare NHS Foundation Trust102
已完成
2 期
A Dehydroepiandrosterone and Pharmacokinetics in Trauma study (ADaPT)Severe trauma injuryInjury, Occupational Diseases, PoisoningInjuries to unspecified part of trunk, limb or body regionISRCTN12961998niversity Hospitals Birmingham NHS Foundation Trust68
已完成
不适用
The use of compression bandages in total knee replacement surgeryISRCTN86903140orthumbria Healthcare NHS Foundation Trust (UK)50
已完成
不适用
A randomized controlled trial of an empowerment intervention for female adolescents with diabetes.Type 1 diabetesNutritional, Metabolic, EndocrineDiabetesISRCTN57528404Karolinska Institute / Södersjukhuset100
已完成
4 期
Web-based investigation of statin side-effectsCardiovascular diseaseISRCTN30952488ondon School of Hygiene and Tropical Medicine200